2 results
Approved WMOCompleted
To evaluate the proportion of patients indicating an overall preference via a Patient Preference Questionnaire (PPQ) for either the subcutaneous (SC) or the intravenous (IV) route of rituximab administration.
Approved WMOPending
to determine the feasibility, repeatability and sensitivity of our newly developed non-invasive dynamic MR acquisitions to study muscle contractile function and muscle oxidative capacity during dynamic exercise. Muscle oxidative capacity will be…